BioTRUST GLP-1 Elevate is manufactured in the USA in a GMP-certified facility using domestic and imported materials and undergoes third-party lab testing to ensure purity, potency and safety.
The pharmacies we have relationships with do not even offer availability of these medications in compounded versions for this reason
The dual GLP-1/amylin mechanism approaches this therapeutic ceiling by multiple and non-overlapping pathways that do not involve compensatory mechanisms that limit the efficacy of single-hormone therapy
Primary outcomes were myocardial infarction (MI), pulmonary embolism (PE), coronary revascularization, transient ischemic attack (TIA) or stroke, and venous thromboembolism (VTE)
The platform is young, and the clinical infrastructure (CareGLP, named pharmacy partners, and LegitScript certification) checks out